Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The Injection (Subcutaneous) - Dosing: Once weekly - Bioavailability: ~100% (bypasses GI tract) - Weight loss in trials: Up to 22% at 36 weeks - Best for: Patients seeking maximum efficacy, comfortable with self-injection The Pill (Oral) - Dosing: Once daily (taken on an empty stomach, similar to Rybelsus) - Bioavailability: Lower than SC (relies on SNAC absorption technology) - Weight loss in trials: Up to 13.1% at 12 weeks (Phase 1 short duration) - Best for: Injection-averse patients, early treatment, maintenance, broader access The oral formulation will almost certainly deliver less weight loss than the subcutaneous version at equivalent treatment durations
Together, they form a powerhouse treatment that helps your body rebuild from the inside out
However, Retatrutide is still considered an investigational compound , and most information about dosage comes from clinical trials rather than widespread medical use
These outcomes could transition to us successfully, but most human evidence is anecdotal
It's water-soluble, so your body flushes out what it doesn't use, and there's no established toxic dose for healthy people
Satisfied customer so far
US$ 24.31
US$ 25.84
US$ 21.51
US$ 21.77
US$ 24.50
